HPTN Publications

Stringer JS, Sinkala M, Goldenberg R, Vermund S, Acosta E . Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet. 2003, 362: 667

Stringer JS, Sinkala M, Goldenberg RL, Kumwenda R, Acosta EP, Aldrovandi GM, Stout JP, Vermund SH . Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS. 2004, 18: 939-43

Stringer JS, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH . Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health. 2002, 92: 365-6

Sucato G, Celum CL, Dithmer D, Ashley RL, Wald A . Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescehts. Pediat Infect Dis. 2001, 20: 422-6

Sugarman J, Barnes M, Rose S, Dumchev K, Sarasvita R, Viet HT, Zeziulin O, Susami H, Go V, Hoffman I, Miller WC . Development and Implementation of Participant Safety Plans for International Research with Stigmatised Populations [HPTN 074]. Lancet HIV. 2018, 5: 468-472

Sugarman J, Corneli A, Donnell D, Liu TY, Rose S, Celentano D, Jackson B, Aramrattana A, Wei L, Shao Y, Liping F, Baoling R, Dye B, Metzger D . Are there adverse consequences of quizzing during informed consent for HIV research?. J Med Ethics. 2011, 37: 693-7

Sugarman J, Grace WC . Ethics and the standards of prevention in HIV prevention trials - comment. AIDS. 2010, 24: 2298-9 PMID:20736687

Sugarman J, Mayer KH . Ethics and pre-exposure prophylaxis for HIV infection. J Acquir Immune Defic Syndr. 2013, 63: S135-9